DOI QR코드

DOI QR Code

Brain meningioma in a patient with systemic lupus erythematosus

  • Yoo, Byung-Woo (Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Ahn, Sung-Soo (Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Pyo, Jung Yoon (Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Byun, Se-Jin (Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Song, Jason Jungsik (Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Park, Yong-Beom (Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Lee, Soo-Kon (Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Song, Jung-Soo (Department of Rheumatology, Chung-Ang University College of Medicine) ;
  • Lee, Sang-Won (Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine)
  • Received : 2015.06.11
  • Accepted : 2015.08.07
  • Published : 2016.11.18

Abstract

Brain meningioma, the most common benign brain tumor, has been reported to account for 13-26% of all intracranial tumors, with a crude incidence rate of 2.3 per 100,000 persons for all types of meningiomas. The prevalence of neuropsychiatric lupus erythematosus is 15-91% and its clinical manifestations are diverse: from mild cognitive dysfunction to serious neurological or psychiatric symptoms. Here, we report the first Korean patient with brain meningioma and systemic lupus erythematosus who had undergone surgical tumor resection.

Keywords

References

  1. Marosi C, Hassler M, Roessler K, Reni M, Sant M, Mazza E, et al. Meningioma. Crit Rev Oncol Hematol 2008;67:153-71. https://doi.org/10.1016/j.critrevonc.2008.01.010
  2. Rohringer M, Sutherland GR, Louw DF, Sima AA. Incidence and clinicopathological features of meningioma. J Neurosurg 1989;71:665-72. https://doi.org/10.3171/jns.1989.71.5.0665
  3. Schneider B, Pulhorn H, Rohrig B, Rainov NG. Predisposing conditions and risk factors for development of symptomatic meningioma in adults. Cancer Detect Prev 2005;29:440-7. https://doi.org/10.1016/j.cdp.2005.07.002
  4. Huizinga TW, Diamond B. Lupus and the central nervous system. Lupus 2008;17:376-9. https://doi.org/10.1177/0961203308090112
  5. Borchers AT, Aoki CA, Naguwa SM, Keen CL, Shoenfeld Y, Gershwin ME. Neuropsychiatric features of systemic lupus erythematosus. Autoimmun Rev 2005;4:329-44. https://doi.org/10.1016/j.autrev.2005.01.008
  6. Jonsen A, Bengtsson AA, Nived O, Ryberg B, Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology (Oxford) 2002;41:1308-12. https://doi.org/10.1093/rheumatology/41.11.1308
  7. Williams HM, Lundberg GA Jr. Systemic lupus erythmatosus, meningioma and carcinoma of the cervix--a case report. 1956. Conn Med 2006;70:453-6.
  8. Castellino G, Rizzo N, Bernardi S, Trotta F, Govoni M. Meningioma and systemic lupus erythematosus: a matter of pure coincidence? Lupus 2009;18:650-4. https://doi.org/10.1177/0961203308099470
  9. Lee CH, Jung KW, Yoo H, Park S, Lee SH. Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc 2010;48:145-52. https://doi.org/10.3340/jkns.2010.48.2.145
  10. Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet 2004;363(9420):1535-43. https://doi.org/10.1016/S0140-6736(04)16153-9
  11. Richardson TT, Cohen PR. Subacute cutaneous lupus erythematosus: report of a patient who subsequently developed a meningioma and whose skin lesions were treated with isotretinoin. Cutis 2000;66:183-8.
  12. Greenstein B, Roa R, Dhaher Y, Nunn E, Greenstein A, Khamashta M, et al. Estrogen and progesterone receptors in murine models of systemic lupus erythematosus. Int Immunopharmacol 2001;1:1025-35. https://doi.org/10.1016/S1567-5769(01)00034-0